ETC BioMedical
News Release
Click CTRL + p to print.
ETC Biomedical Systems Offers New FDA Cleared Hyperbaric Oxygen Therapy (HBOT) Medical Device

Southampton, PA, August 20, 2010 — Environmental Tectonics Corporation's (OTC Bulletin Board: ETCC) ("ETC" or the "Company") Biomedical Systems, a worldwide leader in the development, manufacture of computerized monoplace hyperbaric chambers, today confirmed that it has received FDA 510-k clearance for O.S.C.A.R. ™. O.S.C.A.R. ™ is an acronym for "Operating System for Control And Record Keeping". This computerized system is configured as a stand-alone unit that will operate, control and record whole-body hyperbaric oxygen therapy treatments.

The FDA 510-k clears the way for the use of O.S.C.A.R. ™, the first stand alone computer hyperbaric oxygen control system intended for use as an ancillary device. The innovation behind O.S.C.A.R. ™ is a proprietary software system that allows hyperbaric technicians to program, manage, and reproduce the HBOT protocol time after time with the same accuracy of the first treatment. This proprietary software is included in each of our BARA-MED® computerized monoplace chambers.

ETC Biomedical Systems continues its evolution of offering unique and groundbreaking technology in the field of hyperbaric medicine. The O.S.C.A.R. ™ stand-alone system is a welcome addition to ETC's long line of computerized commercial products in its portfolio

About ETC Biomedical Systems:
ETC Biomedical, is the world's largest manufacturer of computerized monoplace hyperbaric chambers, with over 40 years of history and experience in the field of hyperbaric chamber technology beginning with the placement of our 1st hyperbaric chamber in 1971. Since ETC entered the clinical hyperbaric monoplace market in 1987, we have been a technology leader in the development of computerized hyperbaric chambers and systems. Further information on ETC's hyperbaric products can be found at www.etchyperbaricchambers.com. The Biomedical Systems is a division of Environmental Tectonics Corporation. (www.etcusa.com)

 





ETC designs, develops, installs and maintains aircrew training systems (aeromedical, tactical combat and general), disaster management training systems and services, entertainment products, sterilizers (steam and gas), environmental testing products, hyperbaric chambers and related products for domestic and international customers.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on ETC's current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about ETC's and its subsidiaries that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

These forward-looking statements include statements with respect to the Company's vision, mission, strategies, goals, beliefs, plans, objectives, expectations, anticipations, estimates, intentions, financial condition, results of operations, future performance and business of the company, including but not limited to, (i) potential additional funding by Lenfest, (ii) the potential delisting of the Company's common stock from the American Stock Exchange as a result of the Company's failure to comply with the AMEX listing standards, (iii) projections of revenues, costs of materials, income or loss, earnings or loss per share, capital expenditures, growth prospects, dividends, capital structure, other financial items and the effects of currency fluctuations, (iv) statements of our plans and objectives of the Company or its management or Board of Directors, including the introduction of new products, or estimates or predictions of actions of customers, suppliers, competitors or regulatory authorities, (v) statements of future economic performance, (vi) statements of assumptions and other statements about the Company or its business, (vii) statements made about the possible outcomes of litigation involving the Company; (viii) statements regarding the Company's ability to obtain financing to support its operations and other expenses, and (ix) statements preceded by, followed by or that include the words, "may," "could," "should," "looking forward," "would," "believe," "expect," "anticipate," "estimate," "intend," "plan," or the negative of such terms or similar expressions. These forward-looking statements involve risks and uncertainties which are subject to change based on various important factors. Some of these risks and uncertainties, in whole or in part, are beyond the Company's control. Factors that might cause or contribute to such a material difference include, but are not limited to, those discussed in the Company's Annual Report on Form 10 K for the fiscal year ended February 29, 2008, in the section entitled "Risks Particular to Our Business." Shareholders are urged to review these risks carefully prior to making an investment in the Company's common stock.

The Company cautions that the foregoing list of important factors is not exclusive. Except as required by federal securities law, the Company does not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by or on behalf of the Company.

Contact: Duane D. Deaner, CFO     Tel: 215-355-9100 (ext.1203)     Fax: 215-357-4000    http://www.etcusa.com